Suggestive linkage to chromosome 19 in a large Cuban family with late-onset Parkinson's disease

Mov Disord. 2003 Nov;18(11):1240-9. doi: 10.1002/mds.10534.

Abstract

The identification of disease genes using family-based approaches has provided important insights into the pathogenesis of Parkinson's disease (PD) demonstrating the importance of genetic studies on monogenic forms of the disease. We studied a large Cuban family with typical, late-onset PD and probable autosomal dominant inheritance. Mean age at onset was 61.2 years (+/- 12.53, 45-76). Other phenotypes such as essential tremor and atypical parkinsonism were observed in this family. We carried out a genome-wide scan and linkage analyses. The genetic data were analyzed using a conservative model in which only patients with clinically definite or likely PD were considered affected, other phenotypes were regarded as "unknown." Multipoint analyses yielded a maximum LOD of 2.26 between markers D19S221 and D19S840. Haplotype analysis showed a region on chromosome 19 shared by six of seven PD patients. The essential tremor phenotype and the atypical parkinsonism do not segregate with this haplotype, suggesting a different etiology. Our findings suggest the presence of a novel locus for PD on chromosome 19p13.3-q12. We propose that an oligogenic model with moderate contribution of two or three genes rather than a "pure" monogenic model might explain better the wide range in age at onset, the reduced penetrance and the phenotypical variability observed in PD families.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Antiparkinson Agents / therapeutic use
  • Brain / diagnostic imaging
  • Brain / pathology
  • Chromosomes, Human, Pair 19 / genetics*
  • Female
  • Follow-Up Studies
  • Genetic Linkage / genetics*
  • Haplotypes / genetics
  • Humans
  • Levodopa / therapeutic use
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Parkinson Disease / diagnosis
  • Parkinson Disease / drug therapy
  • Parkinson Disease / genetics*
  • Pedigree
  • Polymerase Chain Reaction
  • Severity of Illness Index
  • Tomography, X-Ray Computed

Substances

  • Antiparkinson Agents
  • Levodopa